|
|
Community Practice Connections&trade: 1st Annual Optometry Times® EyeCon 2021
Target Audience
This educational activity is directed toward optometrists who treat patients with both common and rare ocular conditions. Other health care professionals interested in the diagnosis and management of eye conditions are also invited to participate.
Activity Overview
As the clinicians at the front lines of eye and vision care, doctors of optometry are tasked with diagnosing, treating, and managing ocular disorders and vision changes related to systemic disease. They also... |
|
|
Collaborative Care in Glaucoma: Focus on MIGS
This webinar will focus on the comanagement of patients with glaucoma, specifically those who may be candidates for microinvasive glaucoma surgery procedures that target the trabecular meshwork. Michael Greenwood, MD, and Justin A. Schweitzer, OD, will discuss the ways in which they collaborate to provide the best pre- and postoperative care for these patients.
|
|
|
Evolving Concepts in Anterior Segment Outcomes: Tackling Ocular Surface Disease Video Interview
In this video interview, Douglas K. Devries, OD, discusses the negative impact of undiagnosed and untreated ocular surface disease. He give pearls for comanaging cataract surgery patients, screening for meibomian gland dysfunction, and approaching OSD management in patients with comorbid conditions.
|
|
|
Evolving Concepts in Anterior Segment Outcomes: Comanaging Premium IOL Patients Video Interview
In this video interview, Marc Bloomenstein, OD and Justin Schweitzer, OD discuss comanaging premium intraocular lens patients. How do you talk to patients about presbyopia-correcting and toric IOLs before surgery? What instruments do you rely on to accurately assess preoperative patients? How do you handle difficult patients? How do you address postoperative residual astigmatism? Watch this video to find out!
|
|
|
Evolving Concepts in Anterior Segment Outcomes: Identifying New Treatments for Keratoconus Video Interview
In this video interview, Gloria B. Chiu, OD, FAAO, FSLS, discusses the diagnosis and treatment of early and mild keratoconus, including the use of corneal crosslinking in the management of these patients.
|
|
|
Adapting to Change: Incorporating Telemedicine into Our Practice - For the Optometrist
Although telemedicine is not new to ophthalmology, the 2020 coronavirus pandemic has heightened the need for options that keep patients and eye care providers safe. Eye care providers need to be educated on the changing regulations related to office visits and billing, the enhanced safety measures required, and the ocular conditions best suited for telemedicine. |
|
|
Diabetic Retinopathy: Prevalence, Risk Factors and Early Detection
It is vital that optometrists continue to play a role in educating patients with diabetes about the potential ocular complications of their systemic disorder, as well as the benefits of comprehensive diabetic eye exams and early treatment. This activity reviews the increasing prevalence of diabetes and diabetic retinopathy and focuses on the need for early detection, use of advanced imaging, and timely referral. These points will be also illustrated through case presentations.
|
|
|
Diabetic Retinopathy: Screening, Removing Barriers, and Imaging
In patients with diabetes, there is often no obvious evidence of diabetic retinopathy (DR), ie, no intraretinal hemorrhages, exudates, or obvious microaneurysms. However, some of the newer imaging modalities can detect minor vascular changes much earlier than previous imaging options. This activity will focus on the importance of screening, overcoming barriers to recommended care, early detection through imaging modalities, and the importance of timely referral to a retina specialist for advan... |
|
|
Intravitreal aflibercept injection vs sham as prophylaxis against conversion to exudative age-related macular degeneration in high-risk eyes: a randomized clinical trial
May 2021: VBS Literature Update
Heier JS, Brown DM, Shah SP, et al. Intravitreal aflibercept injection vs sham as prophylaxis against conversion to exudative age-related macular degeneration in high-risk eyes: a randomized clinical trial. JAMA Ophthalmol. 2021 Mar 18:e210221. doi: 10.1001/jamaophthalmol.2021.0221. Epub ahead of print. PMID: 33734306; PMCID: PMC7974836.
Abstracted by Brian K. Do, MD |
|
|
Dry Eye Flares Consensus Roundtable Chapter 1: Definition and Prevalence of Dry Eye Flares
The Dry Eye Flares Consensus faculty define dry eye flares and discuss the prevalence of acute exacerbations of dry eye disease. They describe the signs and symptoms associated with episodic flares of ocular surface disease.
|
|
|
Comparison of 25- and 27-gauge sutureless cannula-based intraocular lens scleral fixation visual acuity outcomes and complication rates
May 2021: VBS Literature Update
Kadakia AB, Wong TP, Wykoff CC, et al. Comparison of 25- and 27-gauge sutureless cannula-based intraocular lens scleral fixation visual acuity outcomes and complication rates. Retina. 2021;41(5):940-946. doi: 10.1097/IAE.0000000000002991. PMID: 33009221.
Abstracted by Maxwell Stem, MD |
|
|
Dry Eye Flares Consensus Roundtable Chapter 3: Current and Emerging Treatment Options for Dry Eye Flares
The Dry Eye Flares Consensus faculty discuss current and emerging treatment options for dry eye flares. They describe best practices for treating acute exacerbations of dry eye disease and discuss how conventional therapies for dry eye disease are not effective against flares. They also describe novel approaches to treat dry eye flares. |
|
|
Dry Eye Flares Consensus Round Table Chapter 2: Impact of Dry Eye Flares and Diagnostic Considerations
The Dry Eye Flares Consensus faculty discuss the impact of dry eye flares on visual outcomes and patient satisfaction. They discuss how best to identify patients with dry eye flares, including diagnostics tools and adjustments to dry eye questionnaires to evaluate these patients.
|
|
|
Diabetic Retinopathy Update: Best Practices in Referrals, Screening, and Treatments
This continuing education activity captures content from a virtual roundtable discussion.
ACTIVITY DESCRIPTION
The overwhelming majority (85%) of comprehensive eye exams are conducted by optometrists. Diabetic retinopathy (DR) is the most common ocular complication of diabetes and is currently responsible for more than 10,000 new cases of blindness each year in the United States alone. This supplement highlights discussion topics among experts in the field and provides important education ... |
|
|
Machine Learning Can Predict Anti–VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema
July 2021: VBS Literature Update
Gallardo, Mathias, et al. “Machine Learning Can Predict Anti–VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema.” Ophthalmology Retina, vol. 5, no. 7, 2021, pp. 604–624., doi:10.1016/j.oret.2021.05.002.
Abstracted by Mohsin H. Ali, MD |
|
|
Geographic Atrophy: Best Practices for Diagnosis and Referral
This roundtable discussion brings together optometric and ophthalmic experts in retinal disease to discuss the state of geographic atrophy (GA), how best to manage patients, and the pipeline therapies that have the potential to significantly alter the course of disease or many patients.
This certified CE/CME activity is designed for optometrists and ophthalmologists. |
|
|
DR & DME: Addressing Barriers to Early Treatment
This continuing education (CE) activity captures content from a virtual roundtable discussion.
This supplement summarizes a roundtable discussion among retina specialists and optometrists on the topic of collaboration for improved care of patients with diabetes. The clinicians review the latest trial data and share their experiences related to the importance of imaging and how early treatment can preserve vision in patients with diabetes.
This certified CE activity is designed for optome... |
|
|
Dry Eye Flares Consensus Statement: Treating Flares vs. Chronic Dry Eye Disease Part 3
Drs. Eric D. Donnenfeld and Preeya K. Gupta discuss strategies to treat dry eye patients, as compared to patients with dry eye flares. This is Part 3 of 3.
|
|
|
Dry Eye Flares Consensus Statement: Diagnosing and Treating Dry Eye Flares Part 2
Drs. Eric D. Donnenfeld and Preeya K. Gupta discuss the key tests they use to diagnose dry eye flares. They also discuss treatment options for patients with dry eye flares. This is Part 2 of 3. |
|
|
Dry Eye Flares Consensus Statement: Definition and Impact of Dry Eye Flares Part 1
Drs. Eric D. Donnenfeld and Preeya K. Gupta define acute exacerbations of dry eye disease as flares and discuss the impact of dry eye flares on a patient’s quality of life as well as surgical outcomes. This is Part 1 of 3. |
|
|
Modernizing Medical Retina: Review of the Pipeline - Supplement
This continuing medical education (CME) activity captures content from a virtual roundtable discussion.
This supplement summarizes an in-depth discussion into the available options for treatment of retinal diseases and the challenges faced by retina specialists in the current environment of COVID-19, in addition to patient compliance with demainding regimens. The faculty also reviews therapies under investigation for these conditions and the potential they have for longer duration and impro... |
|
|
How Treatments for DR/DME are Modernizing Medical Retina
Content Source
This continuing medical education (CME) activity captures content from a virtual roundtable discussion.
Activity Description
This supplement summarizes an in-depth discussion into the available treatment options for diabetic retinopathy (DR) and diabetic macular edema (DME), as well as the challenges faced by retina specialists and patients in the current environment of COVID-19. The faculty also reviews emerging therapies and the potential they have for longer duration and... |
|
|
Epiretinal Membrane Surgery After Retinal Detachment Repair: Visual Acuity Outcomes and OCT Analysis
August 2021: VBS Literature Update
Soares RR, Mahmoudzadeh R, Salabati M, et al. Epiretinal membrane surgery after retinal detachment repair: Visual acuity outcomes and OCT analysis. Ophthalmol Retina. 2021:S2468-6530(21)00103-2.
Abstracted by Dan Su, MD |
|
|
Presbyopia Management: Matching Today's Presbyopia-correcting Innovations With Specific Patient Needs
CONTENT SOURCE
This continuing medical education (CME) activity captures content from a series of five webinars.
ACTIVITY DESCRIPTION
This supplement summarizes a series of webinars on presbyopia-correcting intraocular lenses (IOLs). The extensive panel of experts reviews the latest research and their personal experience with the current options for managing presbyopia and a review of IOLs in the pipeline.
TARGET AUDIENCE
This certified CME activity is designed for ophthalmologists. |
|
|
Matching Presbyopia-Correcting Technology to the Individual Cataract Patient's Needs
Drs. Constance Okeke and Brandon Ayres describe their current treatment strategies for patients seeking spectacle independence and vision at all distances. They discuss how to manage patient expectations for presbyopia correcting IOL patients during the preoperative consultation, and how to determine the visual distance needs of presbyopia patients. They describe how they manage patients with comorbid conditions, like glaucoma, post-corneal refractive surgery, and other corneal abnormalities. |
|
|
Innovations in Pharmacological Treatments for Presbyopic Patients
Drs. Marjan Farid and Nicole Fram discuss the key efficacy, safety, and comfort considerations when using these new pharmaceutical presbyopia treatments. They also describe the patients that will be the best candidates for pharmaceutical presbyopia treatments.
|
|
|
Risk factors for severe bleeding complications in vitreoretinal surgery and the role of antiplatelet or anticoagulant agents
September 2021: VBS Literature Update
Lauermann P, Klingelhöfer A, Mielke D, et al. Risk factors for severe bleeding complications in vitreoretinal surgery and the role of antiplatelet or anticoagulant agents. Ophthalmol Retina. 2021;5(8):e23-e29.
Abstracted by Wenlan (Wendy) Zhang, MD |
|
|
KOL Knockout™ — Cataract Edition: Surgeons Battling for the Best Outcomes
This continuing medical education (CME) activity captures content from a three live virtual symposia.
ACTIVITY DESCRIPTION
This supplement summarizes content from a series of three unique, live virtual symposia hosted by Uday Devgan, MD, FACS, FRCS. The game show-style quiz competition with real-time audience voting featured cataract-focused case studies and discussions regarding patient care and surgical approaches among seven key opinion leaders/contestants. The archived video series can... |
|
|
Neurotrophic Keratitis: A “Rare Disease” Yet Common Problem
This continuing medical education (CME) activity captures content from a live symposium.
Based on a live satellite symposium held during the American Society for Cataract and Refractive Surgeons Annual Meeting, this supplement summarizes the presentations on the stages of neurotrophic keratitis and the available treatments.
This certified CME activity is designed for ophthalmologists. |
|
|
Roundtable Discussion Part 3: New and Emerging Pharmaceutical Presbyopia Treatments
Drs. Paul Karpecki, Derek Cunningham, Ben Gaddie, Cecelia Koetting, Jack Schaeffer, and Gina Wesley discuss the impact of presbyopia progression on a patient’s quality of life. |
|
|
Roundtable Discussion Part 2: Identifying and Diagnosing Presbyopia Patients
Drs. Paul Karpecki, Derek Cunningham, Ben Gaddie, Cecelia Koetting, Jack Schaeffer, and Gina Wesley discuss best practices for identifying and diagnosing presbyopia patients. |
|
|
Preparing for the Future: Updates in Retinal Diseases and Novel Therapies
This webinar is one in a series of educational initiatives designed to encourage collaborative care between primary eye care providers and retina specialists who practice in the same regions of the country.
Retina Specialist Ehsan Rahimy, MD, summarizes the current therapy options for diabetic eye disease and wet age-related macular degeneration (AMD) and addresses the challenges facing clinicians tasked with managing patients with these retinal diseases. Dr. Rahimy also provides the latest... |
|
|
Pneumatic Vitreolysis with C3F8 for Vitreomacular Traction With and Without Macular Hole: DRCR Retina Network Protocols AG and AH
October 2021: VBS Literature Update
Chan CK, Mein CE, Glassman AR, et al. Pneumatic Vitreolysis with C3F8 for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH. Ophthalmology. 2021;S0161-6420(21)00353-5.
Abstracted by Joshua Levinson MD |
|
|
Clinical Outcomes and Treatment Course of Eyes With Neovascular Age-Related Macular Degeneration Following the Development of Endophthalmitis
October 2021: VBS Literature Update
Koulisis N, Moysidis S, Govindaraju V, et al. Clinical Outcomes and Treatment Course of Eyes with Neovascular Age-Related Macular Degeneration Following the Development of Endophthalmitis. Retina 2021; 41(6):1242-1250.
Abstracted by Judy J Chen, MD |
|
|
Recognition and Referral: Best Practices for Managing Patients with GA
Patients with advanced dry age-related macular degeneration can present with geographic atrophy (GA), a disease that is progressive and increases with age. Although there is no treatment approved by the FDA that halts or reverses GA, a number of drugs in the pipeline are designed to address GA progression, hoping to succeed where previous drug candidates failed. This series of regional, interactive, virtual symposia are designed to educate eye care providers on the importance of diagnosis and ... |
|
|
Patient Care Update: Neurotrophic Keratitis Diagnosis, Treatment, and Referrals
Neurotrophic keratitis can lead to epithelial breakdown, impairment of healing, and ultimately to the development of corneal ulceration, melting and perforation.
Watch the faculty discuss the potential causes of neurotrophic keratitis, how to differentiate it from similar diseases, and when referrals may be necessary. Treatment options are also discussed, including the mechanisms of action of newer therapies and when they should be introduced. |
|
|
Telehealth-based Eye Care During the COVID-19 Pandemic: Utilization, Safety, and the Patient Experience
October 2021: VBS Literature Update
Newman-Casey PA, De Lott L, Cho J, et al. Telehealth-based eye care during the COVID-19 pandemic: utilization, safety, and the patient experience. Am J Ophthal. 2021;230:234–42.
Abstract by Jaya B. Kumar, MD |
|
|
Microcystic Macular Edema and Cystoid Macular Edema Before and After Epiretinal Membrane Surgery
October 2021: VBS Literature Update
Lee DH, Park SE, Lee CS. Microcystic macular edema and cystoid macular edema before and after epiretinal membrane surgery. Retina. 2021;41(8):1652-59.
Abstract by Edward H. Wood, MD |
|
|
Long-term Anti-vascular Endothelial Growth Factor Treatment for Neovascular Age-related Macular Degeneration: the LATAR Study
October 2021: VBS Literature Update
Spooner K, Fraser-Bell S, Hong T, et al. Long-term anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: the LATAR study. Report 1: ten-year, real-world outcomes. Ophthalmol Retina. 2021;5(6):511-18.
Abstracted by Vlad Matei, MD |
|
|
Laser Treatment After Minimized Eye Movement for Repair of Retinal Detachment
October 2021: VBS Literature Update
Kokame GT, Yee S, Omizo JN, Villanueva L, Liu J. Laser Treatment after minimized eye movement for repair of retinal detachment. Ophthalmol Retina. 2021;5(9):939-941. doi: 10.1016/j.oret.2021.01.014. Epub 2021 Jan 30. PMID: 33529816.
Abstract by Avni P. Finn, MD, MBA
|
|
|
End-of-study Results for the Ladder Phase 2 Trial of the Port Delivery System With Ranibizumab for Neovascular Age-related Macular Degeneration
October 2021: VBS Literature Update
Khanani A, Callanan D, Dreyer R, et al. End-of-study results for the Ladder phase 2 trial of the Port Delivery System with ranibizumab for neovascular age-related macular degeneration. Ophthalmol Retina. 2021;5:775-87.
Abstract by Philip Storey, MD, MPH |
|
|
Development of Macular Atrophy After Pars Plana Vitrectomy for Myopic Traction Maculopathy and Macular Hole Retinal Detachment in Pathologic Myopia
August 2021: VBS Literature Update
Fang, Y et al. Development of macular atrophy after pars plana vitrectomy for myopic traction maculopathy and macular hole retinal detachment in pathologic myopia. Retina. 2020;40(10):1881-93. DOI: 10.1097/IAE.0000000000002709.
Abstract by Musa Abdelaziz, MD |
|
|
Treating Presbyopia: New Approaches to a Familiar Problem
Content Source
This continuing medical education (CE/CME) activity captures content from a live symposium at ASCRS.
Activity Description
Based on a live symposium held during the American Society for Cataract and Refractive Surgeons Annual Meeting, this supplement summarizes the presentations on how to manage presbyopic changes with a variety of current and newly emerging treatment options, and how strategies may work synergistically.
Target Audience
This certified continuing me... |
|
|
Diabetic Eye Disease Pipeline Therapies Part 1: Faricimab, KSI-301, and OPT-302
This discussion with Program Chair Christina Y. Weng, MD, MBA, and David A Eichenbaum, MD, includes a case study that highlights challenges with managing diabetic eye disease during the COVID era and how longer duration therapies could be beneficial.
Drs. Weng and Eichenbaum also converse about the latest data on pipeline therapies for diabetic macular edema, including faricimab, KSI-301, and OPT-302. |
|
|
Combating Diabetic Eye Disease and Patients at Risk for Loss to Follow-Up
Retina Specialists Allen C. Ho, MD, FACS, and Katherine Talcott, MD, discuss three complex patient cases and ways to limit loss to follow-up in patients with diabetic eye disease. |
|
|
Challenges With Postoperative Posterior Segment Inflammation
Research indicates that sustained-release implants may have better efficacy and fewer systemic side effects when treating posterior segment uveitis than other corticosteroid delivery options or alternative nonsteroidal treatments. To provide the best treatment possible for patients undergoing eye surgery, ophthalmologists must have a thorough understanding of all available options and their benefits and challenges.
This webinar will include a lively discussion on current postoperative ther... |
|
|
Innovations in Phacoemulsification Devices and Techniques in 2021
Content Source
This continuing medical education (CME) activity captures content from a virtual roundtable.
Activity Description
This supplement describes the differences between phaco pumps, innovations in phaco, and how to use techniques in complex cases.
Target Audience
This certified CME activity is designed for cataract surgeons. |
|
|
Diabetic Eye Disease Pipeline Therapies Part 3: Brolucizumab & PDS
This discussion with Program Chair Christina Y. Weng, MD, MBA, and Sophie J. Bakri, MD, includes a case study that highlights challenges with managing diabetic eye disease during the COVID era and how longer duration therapies could be beneficial.
Drs. Weng and Bakri also converse about the latest data on pipeline therapies for diabetic macular edema, including brolucizumab & PDS. |
|
|
Preparing for the Future: Updates in Retinal Diseases and Novel Therapies
Content Source
This continuing education (CE) activity captures content from a virtual roundtable discussion.
Activity Description
Based on a roundtable discussion in August, this supplement summarizes the challenges facing clinicians when managing diabetic eye disease and wet age-related macular degeneration (AMD) and the current and pipeline therapy options for these diseases.
Target Audience
This certified CE activity is designed for optometrists who care for patients with di... |
|
|
Individualizing Glaucoma Treatment: Understanding How to Utilize Traditional and Novel Agents
Join Nathan M. Radcliffe, MD, and Justin Schweitzer, OD, FAAO, as they discuss the ways in which novel therapeutics may help to overcome the challenges and limitations associated with currently available pharmacologic treatment options for ocular hypertension and primary open-angle glaucoma. |
|